









Markets
/
Stocks
/
nasdaq-bbot
/

BridgeBio Oncology Therapeutics Ord Shs

BBOT

12.180USD

-0.340-2.72%

Close 12/22, 16:00（ET）Quotes delayed by 15 min

286.34MMarket Cap

60.33P/E TTM



BridgeBio Oncology Therapeutics Ord Shs

12.180

-0.340-2.72%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of BridgeBio Oncology Therapeutics Ord Shs to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q2

Operating cash flows (indirect method)

Cash flow from continuing operating activities

---298.90K

Net income from continuing operations

--918.31K

Other non-cash items

--19.37K

Change in working capital

--802.41K

-Change in prepaid expenses

--63.71K

Cash from non-recurring investing activities

Cash from operating activities

---298.90K

Investing cash flow

Cash from non-current investing activities

Financing cash flow

Net cash from non-recurrent financing activities

Net cash flow

Beginning cash balance

--963.13K

Current period cash flow changes

---298.90K

Ending cash balance

--664.23K

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

